Case Study: Reimagining a Fortune 20 HealthTech Brand for the Future of Human Longevity
A global Fortune 20 healthtech company long known for its clinical innovation and precision diagnostics was faced a shifting landscape. Emerging longevity startups were redefining what “health” meant, moving the conversation from disease treatment to lifespan extension.
Case Study: Reimagining a Fortune 20 HealthTech Brand for the Future of Human Longevity Read More »